How exercising in hot weather affects blood sugar in people with type 1 diabetes.
Official title: The Effect of Acute Heat Exposure on Glucose Use During Moderate-intensity Exercise in People With Type 1 Diabetes
Run by Liverpool John Moores University · NCT07341243 · Data updated 2026-11-12
This study will test whether 40 minutes of moderate exercise in hot conditions changes blood sugar during exercise and for 30 minutes afterward in adults with type 1 diabetes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 38 (estimated) |
| Sponsor | Liverpool John Moores University Academic / other |
| Locations | 1 site (Liverpool) |
| Status | Recruiting |
| Started | November 1, 2025 |
| Main results expected | November 1, 2026 |
| Study ends | November 1, 2026 |
| Registry record updated | January 14, 2026 |
| Trial ID | NCT07341243 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–65 with type 1 diabetes diagnosed over one year ago, who regularly do endurance exercise (at least twice weekly for ≥30 minutes) and use MDI, an insulin pump, or a hybrid closed-loop system.
✕Probably not a fit
Patients with recent severe hypoglycaemia, significant cardiovascular or cerebrovascular disease, very high HbA1c (>85 mmol/mol), pregnancy, or those who do not regularly exercise are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, crossover, counterbalanced study has participants complete two laboratory visits performing 40 minutes of moderate-intensity exercise under either temperate (20°C, 50% humidity) or hot (40°C, 50% humidity) conditions. Visits are identical except for temperature, separated by 24 hours, and use continuous glucose monitoring to track blood glucose during exercise and for 30 minutes afterwards. Eligible adults aged 18–65 with type 1 diabetes for more than one year who regularly perform endurance exercise and use multiple daily injections, an insulin pump, or a hybrid closed-loop system will be enrolled. Testing takes place in the Research Institute for Sport and Exercise Sciences laboratories at Liverpool John Moores University.
Why it matters
Potential benefit: If successful, findings could help people with type 1 diabetes plan insulin and exercise strategies to reduce risky high or low blood sugars when exercising in hot weather.
How similar studies have gone: Prior studies suggest temperature can influence glucose responses to exercise, but direct evidence in adults with type 1 diabetes using controlled hot-condition protocols is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * T1D diagnosis more than 1 years ago (to ensure participants are out of the honeymoon period) * Using insulin therapy with multiple daily injections (MDI), insulin pump (pump), or hybrid closed-loop (HCL) o If using a HCL system have experience of using a pre-programmed basal rate in manual mode during exercise * Aged 18-65 years * Regularly engaged in endurance exercise (training at least twice per week for ≥30 minutes per session) Exclusion Criteria: * Pregnancy * \<6 months postpartum or stopped breastfeeding \<1 month before recruitment * Existing cerebrovascular or cardiovascular disease * Significant history of hyperglycaemia (HbA1c \>85 mmol/mol) * History of severe hypoglycaemia requiring third party assistance within the last 3 months * Body weight \<36.5kg * Difficulty swallowing tablets * Appointment for an MRI test that cannot be rescheduled * Obstructive gastrointestinal disease * History of gastrointestinal surgery * Have an implanted medical device
Where it's running
-
Liverpool John Moores University
Liverpool, United Kingdom Recruiting
Study contacts
- Study coordinator: Matthew Cocks, PhD
- Email: m.s.cocks@ljmu.ac.uk
- Phone: 447540191292
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Intermittent CGM Use in high-risk children and teens with Type 1 Diabetes in the Dominican Republic
This study tests whether using the Dexcom G7 intermittently, along with pediatric care and support, can improve glucose control in 10–19 year-olds with high-risk Type 1 Diabetes in the Dominican Republic.
-
AI-assisted remote insulin pump optimization for people with type 1 diabetes
This study tests an AI-powered tool that suggests insulin pump settings for people with type 1 diabetes, with doctor-approved recommendations delivered to a mobile app.
-
AMX0035 in adults with Type 1 Diabetes
This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.
-
Dietary changes to help adults with Type 1 diabetes and overweight see if moderate carbs, time-restricted eating, or regular calories work
We’re testing three weight-loss approaches in adults with type 1 diabetes who are overweight or obese to see which helps reduce weight safely.
-
Islet re-transplantation after prior graft failure in adults with type 1 diabetes
This study looks at whether giving another islet transplant after a prior failed graft helps adults with type 1 diabetes who have severe swings in blood sugar.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.